Manus
@manusbio
Followers
290
Following
7
Media
36
Statuses
55
Accelerating the Transition to BioAlternatives
Boston, MA
Joined May 2016
We’re counting down to #IFTFirst 2025 in Chicago! In just a few days, the Manus team will be at booth #S1265, ready to share our summer-ready, sugar-free treats and #sustainable, supply-secure citrus BioIngredients, Made by Manus™. Learn more: https://t.co/62tRIUvPKl
0
0
0
Heading to #IFTFirst 2025 next week in Chicago? Let’s connect! Manus will be at Booth #S1265 at the largest global #foodscience and innovation expo, hosted by @IFT. See you there!
0
0
0
Industrial biotech, built to scale. This week, Manus and @InscriptaInc united to form a new leader in biomanufacturing — delivering real-world impact through scalable bioalternatives. Made to scale. Made to deliver. Made by Manus™ https://t.co/6xaqQSsjEB
manusbio.com
Combined company to leverage cutting-edge end-to-end platform and domestic manufacturing to accelerate commercialization of bioalternative products
0
0
3
We are excited to announce that Manus has received a $32.4 million award from the @HHSGov Defense Production Act Title III Program to support the domestic production of critical essential medicines at population-scale: https://t.co/ULZuOryjay
#biotechnology #biomanufacturing
0
0
3
We are excited to announce a strategic partnership, The Natural Sweetener Alliance, with @tateandlyleplc to expand access to natural sugar reduction solutions. Learn more about stevia Reb M, the first jointly introduced ingredient, and this partnership: https://t.co/DXzFR5evq4
0
1
6
Last week, Manus VP of R&D, Joe Shaw, spoke at SIMB 2024. He touched on key insights and core principles behind Manus’ approach to strain design and metabolic engineering to optimize cell factories using Manus' BioOptimization Cycle™ technology: https://t.co/rduUZpTxBB
0
0
2
Manus CTO, Christine Santos, explains our BioManufacturing Program in-depth and how it can help companies make bioalternatives at scale, enabling them to expand their scale-up and production capacity using our state-of-the-art BioFacility in Augusta: https://t.co/m65BdskOl7.
0
0
3
The Manus team is excited to attend the @TheBioMADE 2024 Member Meeting on May 29-31 in Minneapolis, MN. This exciting conference brings together BioMADE members and the U.S. Government to participate in member discussions about the latest trends in technology and more!
0
0
5
While we are busy accelerating the transition to bioalternatives, we took a moment to enjoy time with our amazing team of BioHands, the beautiful weather in Augusta, and some free ice cream! #bioeconomy #biomanufacturing #biotechnology #syntheticbiology #MadeByManus
0
0
2
Join Manus next week as we take you behind the scenes of @SynBioBeta 2024. We’ll be connecting with key players in the industry to discuss bioalternatives and how we deliver the benefits of synthetic biology by bridging the Valley of Death between lab scale and manufacturing.
1
3
5
Chief Technology Officer at Manus, Christine Santos, recently sat down with @SynBioBeta to discuss the potential benefits of bioalternatives, the future of synthetic biology, and how our BioManufacturing Program is helping address industry challenges: https://t.co/dXF8bnBomX
0
1
5
Manus CTO, Christine Santos, spoke with @SynBioBeta about the future of bioalternatives: https://t.co/N0CILFLH0e At Manus, we engineer bioalternatives to replicate nature, creating cost-effective, reliable, and sustainable molecules for use in everyday products.
0
1
3
To change the #syntheticbiology industry takes purpose, commitment, and an unwavering drive to challenge the status quo. That’s what our new Chief Business Officer, David Muldoon, brings to the table, along with more than 25 years of deep industry and value chain experience.
0
0
5
Join Waleed Nasser and David Tennenhouse from the @NSF as they discuss their $80 million in funding opportunities that support endeavors specifically aimed at growing the U.S. #bioeconomy. Register now: https://t.co/gNUN72HDzw
#bioeconomy #syntheticbiology @SynBioBeta
The U.S. National Science Foundation (NSF) recently published $80 million in funding opportunities designed to accelerate key scientific areas that will enable new applications of importance to the U.S. #bioeconomy. Join us for this live Q&A session: https://t.co/57oLtHUo1a
0
1
1
At Manus, we are accelerating the transition to bioalternatives by delivering the benefits of synthetic biology, today. We're excited to share our vision and expand the possibilities with our customers, partners, and industry peers through our new site: https://t.co/MEFhp7oMME
0
0
5
Innovation requires both an understanding of what’s come before and the courage to change it. 2024 is a big year for bioalternatives. We invite you to join the transition with us. Stay tuned for more. #biomanufacturing #biotechnology #syntheticbiology #MadeByManus
0
1
3
The White House just took a vital step in announcing the launch of the National Bioeconomy Board focused on increasing U.S. competitiveness in #biotechnology and #biomanufacturing:
0
0
3
Georgia was recently named as one of six states for consideration as potential sites to create a network of bioindustrial manufacturing pilot facilities by @TheBioMADE, a Manufacturing Innovation Institute sponsored by the U.S. Department of Defense:
biomade.org
California, Georgia, Hawaii, Indiana, Iowa, and North Carolina are in review for BioMADE’s pilot-scale facilities MINNEAPOLIS-ST. PAUL, MN/EMERYVILLE, CA , March 13, 2024 – Today, BioMADE , a...
0
0
4
An important article from @TheBioMADE Chief Manufacturing Officer, Jack Starr, on the emergence of the U.S. bioindustrial revolution: https://t.co/UZNgGNQoLO
#bioeconomy #biomanufacturing #biotechnology #syntheticbiology #MadeByManus
0
2
6